Trials / Completed
CompletedNCT00199563
Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels
The Use and Efficacy of Sildenafil in Diabetic Men With Erectile Dysfunction: the Impact on Endothelial Function, a Pilot Feasibility Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
* To evaluate the impact of nightly sildenafil vs placebo use on diabetic men with and without proven endothelial dysfunction and coexisting erectile concerns. * To determine if chronic sildenafil use compared to placebo positively impacts endothelial function among a cohort of diabetic mend with erectile dysfunction * To assess the salvage rate of sildenafil - failures who demonstrate improved response rates over time with chronic use * To assess if microalbuminuria predicts flow-mediated dilation (FMD) response * To measure and identify if other patient specific characteristics predict for sildenafil erectile response and flow-mediated dilatation (FMD) response over time (patient specifics; blood pressure, HBA1c, weight, BMI, age IIEF score at baseline)
Detailed description
60 type II diabetic men with erectile dysfunction will be enrolled in this trial, evaluated over a 12 week period. Randomization into one of two arms (placebo, daily sildenafil 50mg) will be a doubly blinded. Subjects will be followed by IIEF, diaries and brachial forearm medial dilatation duplex scans, urinary microalbuminuria and serum chemistry. Study time-points are at baseline, 6 and 12 weeks. Study participants will be instructed to use the study medication at the specified frequency but will be allowed flexibility to suit their erectile needs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Viagra | Sildenafil 100mg daily for 12 weeks |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2007-10-01
- Completion
- 2007-12-01
- First posted
- 2005-09-20
- Last updated
- 2018-11-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00199563. Inclusion in this directory is not an endorsement.